InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by PITZER KENNETH R, Deputy Chief Executive. Director active across 1 companies, notably Theravance Biopharma, Inc.. In total, 9 disclosures have been published. The latest transaction was filed on 18 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€230,80427,299 shares@ €8.45470.028% mcap44.1% of flow
Ordinary Shares
SEC:0001415889-22-001701:0·
052,000 shares0
Ordinary Shares
SEC:0001415889-22-001184·
052,000 shares0
Ordinary Shares
SEC:0001415889-22-001184:0·
€31,6944,310 shares@ €7.35370.0038% mcap21.7% of flow
Ordinary Shares
SEC:0001415889-21-005469·
€31,6944,310 shares@ €7.35370.0038% mcap6.1% of flow
Ordinary Shares
SEC:0001415889-21-005469:0·
€51,8244,307 shares@ €12.03260.0062% mcap35.4% of flow
Ordinary Shares
SEC:0001179110-21-008398·
€51,8244,307 shares@ €12.03260.0062% mcap9.9% of flow
Ordinary Shares
SEC:0001179110-21-008398:0·
€62,7534,310 shares@ €14.55990.0075% mcap42.9% of flow
Ordinary Shares
SEC:0001179110-21-005846·
€62,7534,310 shares@ €14.55990.0075% mcap12.0% of flow
Ordinary Shares
SEC:0001179110-21-005846:0·
9 of 9 declarations
About PITZER KENNETH R
Kenneth R. Pitzer is Senior Vice President, Head of Product Strategy and Communication Planning at Theravance Biopharma, Inc., a biopharmaceutical company. In his role, he oversees product and communication strategies, contributing to the company's innovation. His expertise is essential for Theravance in its mission to improve healthcare.
